ArticleEpidemics2021
Assessing the effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in Belgium by means of an extended SEIQRD model and public mobility data.
Article in Epidemics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A scoping review of COVID-19 modelling studies in Belgium 2020-2024: incorporation of behaviour and lessons learned.Archives of public health = Archives belges de sante publique · 2026Pooled it
- Modelling the impact of behavioural interventions during pandemics: A systematic review.PloS one · 2025Pooled it
- Social Contagion in COVID-19 Discussions Within the Belgian Reddit Community: Statistical and Modeling Study.Journal of medical Internet research · 2026Article
- Inference on spatiotemporal dynamics for coupled biological populations.Journal of the Royal Society, Interface · 2024Article
- Review
- Wording the trajectory of the three-year COVID-19 epidemic in a general population - Belgium.BMC public health · 2024Article
- A Stochastic Mobility-Driven Spatially Explicit SEIQRD covid-19 Model with VOCs, Seasonality, and Vaccines.Applied mathematical modelling · 2023Article
- How contact patterns during the COVID-19 pandemic are related to pre-pandemic contact patterns and mobility trends.BMC infectious diseases · 2023Article
- Mobility and the spatial spread of sars-cov-2 in Belgium.Mathematical biosciences · 2023Article
- Mathematical Model of COVID-19 Pandemic with Double Dose Vaccination.Acta biotheoretica · 2023Article
- Session 3 of the RSS Special Topic Meeting on Covid-19 Transmission: Replies to the discussion.Journal of the Royal Statistical Society. Series A, (Statistics in Society) · 2022Article
- On the role of financial support programs in mitigating the SARS-CoV-2 spread in Brazil.BMC public health · 2022Article
- Leveraging artificial intelligence and data science techniques in harmonizing, sharing, accessing and analyzing SARS-COV-2/COVID-19 data in Rwanda (LAISDAR Project): study design and rationale.BMC medical informatics and decision making · 2022Article
- Nowcasting and forecasting COVID-19 waves: the recursive and stochastic nature of transmission.Royal Society open science · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a compartmental extended SEIQRD metapopulation model for SARS-CoV-2 spread in Belgium. We demonstrate the robustness of the calibration procedure by calibrating the model using incrementally larger datasets and dissect the model results by computing the effective reproduction number at home, in workplaces, in schools, and during leisure activities. We find that schools and home contacts are important transmission pathways for SARS-CoV-2 under lockdown measures. School reopening has the potential to increase the effective reproduction number from R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.